GLAND.BO

Healthcare Drug Manufacturers - Specialty & Generic

Gland Pharma Limited

₹2,952.60
+39.60 +1.36% today

Price History

Not enough data

Key Stats

Market Cap
487.21B
Avg Volume
238,484
P/E (TTM)
43.72
EPS
₹68.47
52W High
₹3,041.95
52W Low
₹1,575.00
Div. Yield
0.7%

Analyst Ratings

Buy
3
Str Buy
7
Buy
0
Hold
3
Sell
1
Str Sell

Valuation

Forward P/E
30.62
P/B Ratio
4.70
P/S Ratio
7.24
EV/EBITDA
26.11
EV/Revenue
6.68

Margins

Gross Margin 59.2%
Operating Margin 21.0%
Net Margin 16.8%
EBITDA Margin 25.6%

Growth & Returns

Revenue Growth (YoY)
19.6%
Earnings Growth (YoY)
46.9%
Earnings Growth (QoQ)
47.1%

Liquidity & Leverage

Debt / Equity
0.03
Total Cash
33.59B
Total Debt
2.84B

About

Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. It engages in research and development of active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company also offers its products for various therapeutic categories, such as anti- diabetic, anti-malarial, anti-infectives, anti-neoplastic, and neurological and central nervous system; blood related, ophthalmics and otologicals, cardiac, gastro-intestinal, and hormonal products; pain, neuromuscular blocking agents, and analgesics; respiratory and pulmonology; and vitamins, minerals, and nutrients. In addition, it provides contract development, dossier preparation, and technology transfer services. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.

www.glandpharma.com